Patients with cancer requiring VTE prophylaxis after surgery or VTE treatment
Apixaban and rivaroxaban
ASCO guidelines have been updated to include apixaban and rivaroxaban for extended VTE prophylaxis after cancer surgery, and apixaban for VTE treatment.
Apixaban and rivaroxaban were added as options for extended pharmacologic thromboprophylaxis after cancer surgery, with a weak strength of recommendation. Apixaban was also added as an option for the treatment of VTE, with high quality of evidence and a strong recommendation.Additional information is available at www.asco.org/supportive-care-guidelines.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nigel S. Key
University of North Carolina at Chapel Hill
Alok A. Khorana
Cardio-Oncology
Nicole M. Kuderer
Advanced Dermatology
Journal of Clinical Oncology
University of Washington
University College London
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...
Key et al. (Wed,) studied this question.
synapsesocial.com/papers/69d56dc475589c71d767d064 — DOI: https://doi.org/10.1200/jco.23.00294